Evaluating long-term outcomes of TAVR for aortic valve disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry focuses on assessing the long-term prognosis and durability of transcatheter aortic valve replacement (TAVR) in patients with severe aortic valve stenosis or insufficiency. It will collect baseline characteristics, procedural data, and clinical outcomes in a real-world setting to provide insights into the effectiveness of TAVR over time. The study aims to gather comprehensive data to better understand patient outcomes following this intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients diagnosed with severe aortic valve regurgitation undergo evaluation by the Heart team and are eligible for TAVR therapy.

2\. Patients who understand the purpose of this study, agree to participate in the trial and sign the informed consent form

* 1\. Patients with aortic stenosis or aortic valve insufficiency who were evaluated by the Heart team and underwent TAVR therapy
* 2\. Patients who understand the purpose of the study, agree to participate in the trial and sign the informed consent form

Exclusion Criteria:

* 1\. Patients who cannot provide informed consent
* 2\. Patients who are participating in other clinical trials

Where it's running

• Xijing Hospital
  Xi'an, Shannxi, China Recruiting

Study contacts

• Study coordinator: Rutao Wang, M.D, Ph.D
• Email: rutaowang@qq.com
• Phone: +86-15091095796

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using photon-counting CT instead of invasive angiography to check coronary arteries before TAVR

  This test will see if a newer photon-counting CT scan (PCD-CT) can safely replace invasive coronary angiography to look for coronary artery disease in adults having TAVR for severe aortic stenosis.

  Recruiting at 2 sites Medical University Innsbruck · Innsbruck and 1 other locations · NCT07107568

• Investigating multiple and mixed heart valve diseases

  This study looks at how common different types of heart valve diseases are and their features by gathering information from patients around the world who have been diagnosed with these conditions.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT06235385

• SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI

  This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.

  Recruiting Erasmus Medical Center · Düsseldorf and 4 other locations · NCT07872020

• J-VALVE versus surgical aortic valve replacement for severe aortic regurgitation

  This study will test whether the J‑VALVE transfemoral valve works as well and is as safe as surgical aortic valve replacement in people aged 65 and older with severe native aortic regurgitation.

  Recruiting at 2 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Hefei, Anhui and 27 other locations · NCT07453407

• Korea VHD Echo Study: Real-World Practice of Aortic, Mitral, and Tricuspid Valves

  This study looks at how valvular heart disease is managed in Korea by reviewing echocardiograms and medical records from multiple centers to see patterns in disease progression and treatment.

  Recruiting at 2 sites Yonsei University · Seoul, Seoul and 1 other locations · NCT07068633

• Surgery versus Trilogy transcatheter valve for treating aortic regurgitation

  This trial tests whether the Trilogy transcatheter heart valve works as well as surgical aortic valve replacement for people with significant native aortic regurgitation.

  Recruiting at 40 sites JenaValve Technology, Inc. · Burlingame, California and 39 other locations · NCT06608823

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.